93 related articles for article (PubMed ID: 7578599)
1. In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldarelli DD; LaFollette S; Preisler HD
Cell Prolif; 1995 Sep; 28(9):497-509. PubMed ID: 7578599
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldareill DD; LaFollette S; Preisler HD
Head Neck; 1996; 18(6):522-8. PubMed ID: 8902565
[TBL] [Abstract][Full Text] [Related]
3. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
4. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
[TBL] [Abstract][Full Text] [Related]
5. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.
Epstein AH; Lebovics RS; Goffman T; Teague D; Fuetsch ES; Glatstein E; Okunieff P; Cook JA
J Natl Cancer Inst; 1994 Dec; 86(23):1775-80. PubMed ID: 7966416
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
Kotelnikov V; Cass L; Coon JS; Spaulding D; Preisler HD
Clin Cancer Res; 1997 May; 3(5):669-73. PubMed ID: 9815735
[TBL] [Abstract][Full Text] [Related]
7. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
[TBL] [Abstract][Full Text] [Related]
8. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines.
Zackrisson B; Flygare P; Gustafsson H; Sjöström B; Wilson GD
Eur J Cancer; 2002 May; 38(8):1100-6. PubMed ID: 12008198
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetics of head and neck cancers.
Kotelnikov VM; Coon JS IV; Haleem A; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Griem K; Preisler HD
Clin Cancer Res; 1995 May; 1(5):527-37. PubMed ID: 9816012
[TBL] [Abstract][Full Text] [Related]
11. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
[TBL] [Abstract][Full Text] [Related]
12. Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts.
Zätterström UK; Engellau J; Johansson MC; Wennerberg J; Kjellén E
Acta Oncol; 1995; 34(2):205-11. PubMed ID: 7718258
[TBL] [Abstract][Full Text] [Related]
13. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
14. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.
Kotelnikov VM; Coon JS; Mundle S; Kelanic S; LaFollette S; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Preisler HD
Clin Cancer Res; 1997 Jan; 3(1):95-101. PubMed ID: 9815543
[TBL] [Abstract][Full Text] [Related]
16. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
Bennett MH; Wilson GD; Dische S; Saunders MI; Martindale CA; Robinson BM; O'Halloran AE; Leslie MD; Laing JH
Br J Cancer; 1992 Jun; 65(6):870-8. PubMed ID: 1616858
[TBL] [Abstract][Full Text] [Related]
17. Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine.
Raza A; Miller MA; Mazewski C; Sheikh Y; Lampkin B; Sawaya R; Crone K; Berger T; Reising J; Gray J
Cell Prolif; 1991 Mar; 24(2):113-26. PubMed ID: 2009317
[TBL] [Abstract][Full Text] [Related]
18. Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
Browman GP; Kanclerz A; Booker L; Daya D; Archibald SD; Young JE; Goldsmith CH
Cell Prolif; 1991 Nov; 24(6):579-85. PubMed ID: 1764538
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
20. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]